Brief CorrespondenceRadiation Exposure During Prostatic Artery Embolisation: A Systematic Review and Calculation of Associated Risks
References (12)
- et al.
Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis
Eur Urol Focus
(2019) - et al.
Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia
Eur Urol
(2020) - et al.
Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases
Eur Urol
(2005) - et al.
Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
BMJ
(2018) - et al.
Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial
BJU Int
(2019) The 2007 recommendations of the International Commission on Radiological Protection. ICRP Publication 103
Ann ICRP
(2007)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Published by Elsevier B.V. on behalf of European Association of Urology.